Search Results
Oct 21, 2025, 08:00 ET Breakthrough clinical trial confirms that GammaTile delivers superior tumor control compared to standard of care for patients with newly diagnosed operable brain metastases
of brain metastases and leptomeningeal disease. Neuro-Oncology. 2021;23(9):1447-1456. Mahajan A, Ahmed S, McAleer MF, et al. Prospective randomized trial of post-operative stereotactic radiosurgery versus observation for completely resected brain metastases. Lancet
More news about: GT Medical Technologies
Oct 20, 2025, 08:37 ET Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch
develop into skin lesions, leading to a decrease in the quality of life of patients with this disease due to severe pain and pruritus. Mycosis Fungoides (MF) and Sézary Syndrome (SS) comprise the majority of CTCL cases. Depending on the type of CTCL, the disease may progress slowly and can take anywhere
More news about: Citius Oncology, Inc.
Oct 20, 2025, 08:00 ET RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF Inhibitor
https://rheumatology.org/patients/rheumatoid-arthritis. Accessed September 22, 2025. Genovese MC, Fleischmann R, Combe B, Hall S, Rubbert-Roth A, Zhang Y, Zhou Y, Mohamed MF, Meerwein S, Pangan AL. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic
More news about: AbbVie
Oct 16, 2025, 10:00 ET Panasonic Introduces LUMIX S9 in Titanium Gold Limited Version
The focus ring can be used as a control ring (*6), enabling for assigning key functions, and the focus rotation direction can be selected in MF mode. Meet the LUMIX Adventure Kits: For creators who
More news about: Panasonic Corporation of North America
Oct 16, 2025, 08:47 ET Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
develop into skin lesions, leading to a decrease in the quality of life of patients with this disease due to severe pain and pruritus. Mycosis Fungoides (MF) and Sézary Syndrome (SS) comprise the majority of CTCL cases. Depending on the type of CTCL, the disease may progress slowly and can take anywhere
More news about: Citius Oncology, Inc.
Oct 14, 2025, 09:05 ET Prolacta Bioscience Approaches 20 Years Nourishing Extremely Premature Babies as #1 Hospital Provider of Human Milk-Based Fortifiers and Formulas
here.5 Since introducing Prolact+ H2MF®, the world's first and only 100% human milk-based fortifier, in 2006, Prolacta has contributed to changing the standard of care for critically
More news about: Prolacta Bioscience
Oct 14, 2025, 08:00 ET Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from NMPA
minimal off-target binding. - Novel cleavable linker: Ensures precise payload release in tumor tissues. - MF-6 payload: A proprietary DNA topoisomerase I inhibitor designed to overcome multidrug resistance (MDR), exhibiting superior plasma stability, controlled
More news about: Mabwell
Oct 14, 2025, 07:30 ET Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma
Additional supportive studies have demonstrated the utility of longer treatment times with a 75% response rate after 18 weeks of treatment (Study RW-HPN-MF-01), the
More news about: Soligenix
Oct 13, 2025, 22:45 ET Incorporação da GLAI e GIB pela GLA e consequente deslistagem do Nível 2
da Companhia e da Gol Investment Brasil S.A., sociedade anônima fechada, inscrita no CNPJ/MF sob o n.º 55.012.370/0001-30 ("GIB") pela Gol Linhas Aéreas S.A., sociedade anônima fechada, inscrita no CNPJ/MF sob o n.º 07.575.651/0001-59 ("GLA"), cujas ações são detidas integralmente pela Companhia
More news about: GOL Linhas Aéreas Inteligentes S.A.
Oct 13, 2025, 22:37 ET Incorporation of GLAI and GIB into GLA and future delisting from Level 2
Gol Investment Brasil S.A., a privately held corporation registered with the CNPJ/MF under No. 55.012.370/0001-30 ("GIB"), into Gol Linhas Aéreas S.A., also a privately held corporation registered with the CNPJ/MF under No. 07.575.651/0001-59 ("GLA"), whose shares are wholly owned by the
More news about: GOL Linhas Aéreas Inteligentes S.A.
Oct 08, 2025, 07:00 ET Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis
would be unlawful. About the Phase 3 SENTRY Trial SENTRY (XPORT-MF-034;
More news about: Karyopharm Therapeutics Inc.
Oct 07, 2025, 08:47 ET Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe
develop into skin lesions, leading to a decrease in the quality of life of patients with this disease due to severe pain and pruritus. Mycosis Fungoides (MF) and Sézary Syndrome (SS) comprise the majority of CTCL cases. Depending on the type of CTCL, the disease may progress slowly and can take anywhere from
More news about: Citius Oncology, Inc.
Oct 07, 2025, 07:30 ET Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma
ongoing investigator-initiated study (protocol # RW-HPN-MF-01), each further supporting the design of the FLASH2 clinical trial. With enrollment proceeding well, Soligenix anticipates providing an enrollment
More news about: SOLIGENIX, INC.
Oct 06, 2025, 11:28 ET LifeZoom Elevates Your Wellness Routine This Autumn with Red Light Therapy Wand
[2] DE Oliveira MF, Johnson DS, Demchak T, Tomazoni SS, Leal-Junior EC. Low-intensity LASER and LED (photobiomodulation therapy) for pain control of the most common musculoskeletal
More news about: Lifezoom
Sep 30, 2025, 10:00 ET Sony Electronics Expands the G Master Series with the Versatile FE 100mm F2.8 Macro GM OSS
focus-dedicated features: a "Full-time DMF switch" enables instant MF (manual focus) by rotating the focus ring, even in AF (autofocus) mode; the "Focus Mode switch" allows instant switching between AF and MF; the "Sliding Focus Ring" enables FULL MF mode, linked to the distance and magnification scales.
More news about: Sony Electronics, Inc.
Sep 30, 2025, 07:30 ET Soligenix Announces Expansion of European Medical Advisory Board for Cutaneous T-Cell Lymphoma
75% response rate after 18 weeks treatment (Study RW-HPN-MF-01), the
More news about: SOLIGENIX, INC.
Sep 23, 2025, 07:30 ET Soligenix Announces Appointment of Former White House Economic Adviser Tomas J. Philipson, PhD as Strategic Advisor
path to adequately address their feedback. Additional supportive studies have demonstrated the utility of longer treatment times (Study RW-HPN-MF-01, see above), the
More news about: SOLIGENIX, INC.
Sep 23, 2025, 03:01 ET Morse Micro Announces Mass Production of MM8108 Wi-Fi HaLow SoC, Modules, Evaluation Kit and HaLowLink 2
Availability With the MM8108 entering mass production, module availability is rapidly expanding to meet growing customer demand. Morse Micro's MM8108-MF15457 reference module is now available to the general public on Mouser.com, while AzureWave's AW-HM677 module is available for high volume customers
More news about: Morse Micro
Sep 15, 2025, 13:53 ET Connected Car Devices Market Surges to USD 100 Billion by 2033, Propelled by 10.5% CAGR - Verified Market Reports®
Integration (Connected Car Technology, Infotainment Systems), By Material Type (Plastic, Metal), By Frequency Band (Low Frequency (LF), Medium Frequency (MF)), By Geographic Scope And Forecast
More news about: Verified Market Reports
Sep 12, 2025, 19:05 ET Desvendando o código do "novo luxo" para os modelos globais da AITO
AITO é em modo totalmente elétrico, o que não só facilita a condução, mas também reduz efetivamente as emissões de carbono. A plataforma SERES MF oferece suporte técnico básico e integração inteligente avançada para aplicações e atualizações de tecnologia Range-Extended. Como a primeira plataforma
More news about: AITO
Sep 12, 2025, 19:02 ET Descubriendo el código de "nuevo lujo" de los modelos de AITO a nivel mundial
eléctrico puro, lo que no solo facilita la conducción, sino que también reduce las emisiones de carbono de una manera eficaz. La plataforma SERES MF ofrece soporte técnico fundamental e integración inteligente avanzada para aplicaciones y actualizaciones de tecnología de autonomía extendida. Esta
More news about: AITO
Sep 12, 2025, 09:40 ET Tajemství „nového luxusu" globálních modelů AITO
ve vozech AITO je v čistě elektrickém režimu, což znamená nejen snadnější řízení, ale především účinné snižování emisí uhlíku. Platforma SERES MF nabízí základní technickou podporu a pokročilou inteligentní integraci pro aplikace a upgrady technologie prodlužování dojezdu. Jako první full-stack
More news about: AITO
Sep 11, 2025, 19:21 ET Entschlüsselung des Codes für „New Luxury" für die globalen Modelle von AITO
AITO-Nutzer im reinen Elektrobetrieb erfolgt, was nicht nur das Fahren erleichtert, sondern auch die CO2-Emissionen effektiv reduziert. Die SERES MF-Plattform bietet grundlegenden technischen Support und fortschrittliche intelligente Integration für Anwendungen und Upgrades der Range-Extended-Technologie.
More news about: AITO
Sep 11, 2025, 19:16 ET Презентация философии «Новая роскошь» в моделях AITO для глобального рынка
приходится на полностью электрический режим, что не только облегчает вождение, но и эффективно снижает выбросы углекислого газа. Платформа SERES MF предлагает базовую техническую поддержку и расширенную интеллектуальную интеграцию для применения технологий увеличения запаса хода и обновлений. Являясь
More news about: AITO
Sep 11, 2025, 19:08 ET Globálne modely AITO odhaľujú kód „nového luxusu"
najazdených kilometrov používateľov AITO je v čisto elektrickom režime, čo nielen uľahčuje jazdu, ale aj účinne znižuje emisie uhlíka. Platforma SERES MF ponúka základnú technickú podporu a pokročilú inteligentnú integráciu pre aplikácie a aktualizácie technológií s predĺženým dojazdom. Ako prvá komplexná
More news about: AITO